Literature DB >> 15385083

Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.

Glenn E Kirsch1, Elena S Trepakova, Jessica C Brimecombe, Serguei S Sidach, Hope D Erickson, Mary C Kochan, Lisa M Shyjka, Antonio E Lacerda, Arthur M Brown.   

Abstract

INTRODUCTION: In vitro evaluation of drug effects on hERG K(+) channels is a valuable tool for identifying potential proarrhythmic side effects in drug safety testing. Patch-clamp recording of hERG K(+) current in mammalian cells can accurately evaluate drug effects, but the methodology has not been standardized, and results vary widely. Our objective was to evaluate two potential sources of variability: the temperature at which recordings are performed and the voltage pulse protocol used to activate hERG K(+) channels expressed in HEK293 cells.
METHODS: A panel of 15 drugs that spanned a broad range of potency for hERG inhibition and pharmacological class was evaluated at both room and near-physiological temperatures using several patch-clamp voltage protocols. Concentration-response analysis was performed with three stimulus protocols: 0.5- and 2-s step pulses, or a step-ramp pattern.
RESULTS: Block by 2 of the 15 drugs tested, d,l-sotalol (antiarrhythmic) and erythromycin (antibiotic), was markedly temperature sensitive. hERG inhibition measured using a 2-s step-pulse protocol underestimated erythromycin potency compared with results obtained with a step-ramp protocol. Using conservative acceptance criteria and the step-ramp protocol, the IC(50) values for hERG block differed by less than twofold for 15 drugs. DISCUSSION: Data obtained at near-physiological temperatures using a step-ramp pattern are highly repeatable and provide a conservative safety evaluation of hERG inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385083     DOI: 10.1016/j.vascn.2004.06.003

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  61 in total

1.  State dependent dissociation of HERG channel inhibitors.

Authors:  D Stork; E N Timin; S Berjukow; C Huber; A Hohaus; M Auer; S Hering
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 2.  High throughput functional screening of an ion channel library for drug safety and efficacy.

Authors:  Arthur M Brown
Journal:  Eur Biophys J       Date:  2008-08-02       Impact factor: 1.733

3.  Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication.

Authors:  P S Joshi; N Sanakkayala; L Kirkpatrick; P S Terse
Journal:  Regul Toxicol Pharmacol       Date:  2019-07-27       Impact factor: 3.271

4.  Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel.

Authors:  Roope Männikkö; G Overend; C Perrey; C L Gavaghan; J-P Valentin; J Morten; M Armstrong; C E Pollard
Journal:  Br J Pharmacol       Date:  2009-08-10       Impact factor: 8.739

5.  Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Authors:  Yayu Tan; Yadong Chen; Qidong You; Haopeng Sun; Manhua Li
Journal:  J Mol Model       Date:  2011-06-10       Impact factor: 1.810

6.  In silico prediction of hERG potassium channel blockage by chemical category approaches.

Authors:  Chen Zhang; Yuan Zhou; Shikai Gu; Zengrui Wu; Wenjie Wu; Changming Liu; Kaidong Wang; Guixia Liu; Weihua Li; Philip W Lee; Yun Tang
Journal:  Toxicol Res (Camb)       Date:  2016-01-14       Impact factor: 3.524

7.  Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 Channels.

Authors:  Maike Mauerhöfer; Christiane K Bauer
Journal:  Biophys J       Date:  2016-08-09       Impact factor: 4.033

Review 8.  Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Chiara Zuliani; Arno Muller; Herman Goossens; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

9.  International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.

Authors:  A S Bass; B Darpo; A Breidenbach; K Bruse; H S Feldman; D Garnes; T Hammond; W Haverkamp; C January; J Koerner; C Lawrence; D Leishman; D Roden; J P Valentin; M A Vos; Y-Y Zhou; T Karluss; P Sager
Journal:  Br J Pharmacol       Date:  2008-08       Impact factor: 8.739

10.  Identification of Ikr kinetics and drug binding in native myocytes.

Authors:  Qinlian Zhou; Andrew C Zygmunt; Jonathan M Cordeiro; Fernando Siso-Nadal; Robert E Miller; Gregery T Buzzard; Jeffrey J Fox
Journal:  Ann Biomed Eng       Date:  2009-04-08       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.